Vaccine News and Research

Latest Vaccine News and Research

Researchers explore immune responses to mpox infections

In new research, researchers demonstrated that individuals recovering from mpox virus (MPXV) infection have neutralizing antibodies that target MPXV antigens A35R and H3L.

17 Jan 2023

Rural seniors benefit from pandemic-driven remote fitness boom

Eight women, all 73 or older, paced the fellowship hall at Malmo Evangelical Free Church to a rendition of Daniel O'Donnell's "Rivers of Babylon" as they warmed up for an hourlong fitness class.

17 Jan 2023

Overall patterns of SARS-CoV-2 caused by variants of concern among children and adolescents

A recent study systematically reviewed COVID-19 among adolescents and children due to SARS-CoV-2 variants of concern.

17 Jan 2023

Mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months

High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months.

16 Jan 2023

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

Researchers from the United States evaluated the efficacy and immunogenicity of an intranasal messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine against SARS-CoV-2 using a hamster model.

16 Jan 2023

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

Researchers conducted a nationwide study in Israel to determine the post-acute sequelae of SARS-CoV-2 a year after mild COVID-19.

16 Jan 2023

What is the effectiveness of a multivalent exosome-based COVID-19 vaccine?

Researchers assessed the effectiveness of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine.

16 Jan 2023

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

Researchers assessed the efficacy of the COVID-19 second booster vaccine compared to the first booster vaccine and the protection conferred by prior COVID-19 infection.

16 Jan 2023

The trajectory of CD4+ T cell responses to mRNA vaccines in older individuals

Researchers investigated how age-related T-cell defects impacted the effectiveness of mRNA-based COVID-19 vaccines.

16 Jan 2023

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

Researchers evaluated antibody responses to the spike proteins of the SARS-CoV-2 Wuhan-Hu-1 strain and VOCs such as the Alpha, Beta, Gamma, Delta, and Omicron.

16 Jan 2023

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Acceptance of COVID-19 vaccines increased overall by 5.2% in 2022 compared to 2021, according to a survey of 160,000 individuals in 23 countries, published in the journal Nature Medicine.

13 Jan 2023

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

In a recent review, the former director of the National Institute of Allergy and Infectious Diseases and former chief medical advisor to the president of the United States (U.S.), Dr. Fauci, and his team review the roadblocks to developing effective vaccines against viruses that infect the human respiratory mucosa and discuss strategies for next-generation vaccine development against mucosal respiratory viruses

13 Jan 2023

Recent findings on original antigenic sin and SARS-CoV-2

Researchers collated the findings of studies relating original antigenic sin with SARS-CoV-2 evolution.

13 Jan 2023

Discovery of a potential new target for new MPOX or broad pox vaccines

In a recent study posted to the medRxiv* preprint server, researchers in the United Kingdom developed a pooled enzyme-linked immunosorbent (ELISA) assay using mpox (MPX) virus (MPXV) antigens and vaccinia virus (VACV) antigens. They also assessed humoral responses to and identification of antigens of MPXV IIa clade and IIb clade, in comparison to recipients of smallpox vaccines (ACAM2000 and IMVANEX).

12 Jan 2023

CNB-CSIC vaccine fully protects against SARS-CoV-2 infection of the brain

In a recent study published in the journal Nature Neuroscience, researchers in Spain described the effectiveness of a modified vaccinia virus Ankara (MVA) vector severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate in protecting against SARS-CoV-2 infection in the brain using a mouse model.

12 Jan 2023

COVID-19 booster doses could significantly reduce the incidence of SARS-CoV-2 infection among young adults

A recent study published in the journal PLOS Medicine examined the effectiveness of booster doses of coronavirus disease 2019 (COVID-19) vaccines in protecting vaccinated young adults against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during the dominant period of the Omicron BA.1 variant.

12 Jan 2023

American Cancer Society's annual report on cancer facts and trends released

Today, the American Cancer Society released Cancer Statistics, 2023, the organization's annual report on cancer facts and trends. According to the report, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths.

12 Jan 2023

Vaccine News and Research

Latest Vaccine News and Research

Researchers explore immune responses to mpox infections

Rural seniors benefit from pandemic-driven remote fitness boom

Overall patterns of SARS-CoV-2 caused by variants of concern among children and adolescents

Mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

What is the effectiveness of a multivalent exosome-based COVID-19 vaccine?

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

The trajectory of CD4+ T cell responses to mRNA vaccines in older individuals

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

Recent findings on original antigenic sin and SARS-CoV-2

Discovery of a potential new target for new MPOX or broad pox vaccines

CNB-CSIC vaccine fully protects against SARS-CoV-2 infection of the brain

COVID-19 booster doses could significantly reduce the incidence of SARS-CoV-2 infection among young adults

American Cancer Society's annual report on cancer facts and trends released

New technique could overcome the delivery hurdles faced by promising mRNA therapies

New research identifies natural compounds with pan-SARS-CoV-2 inhibitory activity

Breast milk of people vaccinated against COVID-19 provides protection to infants, study reveals

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in